The World Health Organization (WHO) on Tuesday said it had prequalified an Ebola vaccine for the first time, hailing a “critical step” towards its licensing, access and roll-out in countries most at risk of outbreaks.
A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine strategy—an approach that may also work in protecting people from an array of other deadly infectious diseases. The team,
A single dose of a highly diluted VSV-Ebola virus (EBOV) vaccine—approximately one-millionth of what is in the vaccine being used to help control the ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC)—remains
The measles can be dangerous for people of all ages, but the highly contagious virus poses a particular threat to pregnant women. That threat was clearly illustrated in a recent case report, which detailed the
Despite the increasing trends in uptake, the human papillomavirus (HPV) vaccine coverage is far behind other infant vaccines in many states, according to a new study, which describes the trends in HPV vaccine uptake in
April 13, 2019 – Pfizer Inc. (NYSE: PFE) announced today the presentation of data from a Phase 2 study of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, being investigated for the prevention of invasive
TUESDAY, March 5, 2019 — Google, Facebook, and Pinterest need to take more action against the growing threat to children posed by online misinformation about vaccines, the American Academy of Pediatrics said in a letter
MONDAY, March 4, 2019 — Amid ongoing U.S. measles outbreaks, one of the largest studies to date provides fresh evidence that the measles, mumps and rubella (MMR) vaccine does not cause autism. Danish researchers found